All FDA drug approvals
FDA data · free, no account
FDA drug approvals in 1956
FDA approved the original submission of 23 new drug and biologics license applications in 1956, from 18 sponsors. FDA marks 21 of them discontinued, every product under the application. From the Drugs@FDA export of 2026-09-03.
| Approved | Brand | Ingredient | Sponsor | Application |
|---|---|---|---|---|
| PREMARIN | estrogens, conjugated | WYETH PHARMS | NDA010402 | |
| CANTIL | mepenzolate bromide | SANOFI AVENTIS US | NDA010679 | |
| MODERIL | rescinnamine | PFIZER | NDA010686 | |
| COMPAZINE | prochlorperazine maleate | GLAXOSMITHKLINE | NDA010571 | |
| HALOTESTIN | fluoxymesterone | PHARMACIA AND UPJOHN | NDA010611 | |
| MAGNACORT | hydrocortamate hydrochloride | PFIZER | NDA010554 | |
| PHENERGAN | promethazine hydrochloride | WYETH AYERST | NDA008857 | |
| BENDECTIN | doxylamine succinate, pyridoxine hydrochloride | SANOFI AVENTIS US | NDA010598 | |
| HYDELTRA-TBA | prednisolone tebutate | MERCK | NDA010562 | |
| PBZ-SR | tripelennamine hydrochloride | NOVARTIS | NDA010533 | |
| ATARAX | hydroxyzine hydrochloride | ROERIG | NDA010485 | |
| ISUPREL | isoproterenol hydrochloride | BAUSCH | NDA010515 | |
| CYTOMEL | liothyronine sodium | KING PHARMS | NDA010379 | |
| MYTELASE | ambenonium chloride | SANOFI AVENTIS US | NDA010155 | |
| LORFAN | levallorphan tartrate | ROCHE | NDA010423 | |
| SPARINE | promazine hydrochloride | HIKMA | NDA010349 | |
| ATARAX | hydroxyzine hydrochloride | PFIZER | NDA010392 | |
| HYPAQUE | diatrizoate sodium | GE HEALTHCARE | NDA011386 | |
| ISOPROTERENOL HYDROCHLORIDE | isoproterenol hydrochloride, isoproterenol sulfate | 3M | NDA010375 | |
| MEDIHALER-EPI | epinephrine bitartrate | 3M | NDA010374 | |
| DILANTIN | phenytoin sodium | PARKE DAVIS | NDA010151 | |
| INVERSINE | mecamylamine hydrochloride | TARGACEPT | NDA010251 | |
| METI-DERM | prednisolone | SCHERING | NDA010209 |